Accelerate Blue Fund

Accelerate Blue Fund is an early-stage venture capital firm based in Ann Arbor, Michigan, that focuses on investing in startups licensed from research conducted at the University of Michigan. Managed by Innovation Partnerships at the university, the fund targets a variety of sectors, including information technology, healthcare, materials and resources, financial services, energy, consumer products and services, business products and services, and commercial transportation. By concentrating on U-M research startups, Accelerate Blue Fund aims to support innovation and foster the growth of emerging companies in the United States.

Don Manfredi

Associate Director

6 past transactions

Newhaptics

Venture Round in 2023
Newhaptics is a microfluidic technology company that specializes in full-page digital braille and tactile graphics displays. The company was founded in 2018 and is based in Ann Arbor, Michigan.

Arcascope

Seed Round in 2022
Arcascope makes apps that utilize algorithms that track circadian rhythms and generates personalized recommendations to help people get their clocks back on track.

CubeWorks

Seed Round in 2022
CubeWorks Inc. specializes in developing millimeter-scale computing solutions, focusing on autonomous wireless sensing technology. Founded in 2013 and based in Ann Arbor, Michigan, the company has created the Cubisens platform, which includes ultra-small wireless smart sensors for various applications such as healthcare logistics, supply chain management, cold chain monitoring, security, and environmental monitoring. These sensors are characterized by their lightweight and durable design, making them suitable for deployment in challenging environments. By enabling real-time tracking and providing critical data access, CubeWorks aims to enhance the Internet of Things (IoT) landscape with innovative sensing solutions that address a wide range of monitoring needs.

INHERET

Seed Round in 2022
INHERET is a developer of decision support software focused on personalized medicine to aid in the prevention and early detection of hereditary diseases. The platform leverages personal and family health history to assess patients' risk for hereditary cancers and other conditions. By generating easy-to-read reports, it provides healthcare professionals with clear next-step recommendations and tailored educational resources. This approach enhances clinicians' ability to accurately identify patients at increased risk, ultimately aiming to improve health outcomes through informed decision-making.

Movellus

Convertible Note in 2021
Movellus develops process portable and ultra-low power analog IPs. Its roducts include PLLs, DLLs, and LDOs, that are optimized per design.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.